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Abstract
Objective: The Nutritional Support for Africans Starting Antiretroviral Therapy
(NUSTART) trial was designed to determine whether nutritional support for
malnourished HIV-infected adults starting antiretroviral therapy (ART) can
improve early survival. Appetite is related to health outcomes in this population,
but the optimal appetite metric for ﬁeld use is uncertain. We evaluated two
measures of appetite with the goal of improving understanding and treatment of
malnutrition in HIV-infected adults.
Design: Longitudinal cohort study embedded in a clinical trial of vitamin and
mineral-fortiﬁed, v. unfortiﬁed, lipid-based nutritional supplements.
Setting: HIV clinics in Mwanza, Tanzania and Lusaka, Zambia.
Subjects: Malnourished (BMI< 18·5 kg/m2) HIV-infected adults starting ART.
Results: Appetite measurements, by short questionnaire and by weight of maize
porridge consumed in a standardized test, were compared across time and
correlated with changes in weight. Appetite questionnaire scores, from polychoric
correlation, and porridge test results were normally distributed for Tanzanians
(n 187) but clustered and unreliable for Zambians (n 297). Among Tanzanian
patients, the appetite score increased rapidly from referral for ART, plateaued at
the start of ART and then increased slowly during the 12-week follow-up. Change
in appetite questionnaire score, but not porridge test, correlated with weight
change in the corresponding two-week intervals (P= 0·002) or over the whole
study (P= 0·05) but a point estimate of hunger did not predict weight change
(P= 0·4).
Conclusions: In Tanzania change in appetite score correlated with weight change,
but single point measurements did not. Appetite increases several weeks after the
start of ART, which may be an appropriate time for nutritional interventions for
malnourished HIV-infected adults.
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The roll out of antiretroviral therapy (ART) in Africa over
the past decade has saved many lives but there remains a
worryingly high risk of mortality in the ﬁrst few months
after starting ART(1). Malnutrition, as indicated by
BMI< 18·5 kg/m2 in adults, is an independent risk factor
for this early mortality(1). However, even under controlled
research conditions, food supplements may not have
efﬁcacy for decreasing mortality(2,3). Well-established
treatment regimens for severe malnutrition in young
children(4) use a two-stage protocol in which metabolic
changes resulting from malnutrition and concurrent
infections are stabilized before larger amounts of
energy are provided for weight regain. Therefore, in our
Nutritional Support for Africans Starting Antiretroviral
Therapy (NUSTART) trial we wished to test whether a
similar two-stage protocol could improve survival of mal-
nourished adults starting ART.
When treating severely malnourished young children, a
key indicator of when a child is ready to move from the
ﬁrst stage of metabolic stabilization to the second stage of
weight gain is return of appetite(4), although this may not
always be observed in HIV-infected malnourished chil-
dren(5). Appetite is also of concern in malnourished
patients starting ART because too rapid an increase in
appetite may result in a harmful refeeding syndrome(6).
A third reason to study appetite of HIV-infected patients is
that some food-insecure patients are reported not to
adhere well to ART because of experiences or fears that
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the ART drugs increase hunger(7,8). We wished to develop
a measure of appetite that would both assist in under-
standing appetite interactions with nutritional metabolism
during ART and aid clinical management of patients.
Published tools for measuring appetite or hunger may
not be applicable to a population of underweight,
seriously ill African adults starting ART; for example, tools
may have been validated for very different populations,
such as obese subjects on low-energy diets or young
African children fed by their mothers(9). Furthermore, the
concept of ‘hunger’ among low-income populations is
often used as overlapping with ‘food security’(10), which is
only one component of appetite and food intake of
interest in the present work. We chose to use two appetite
tests: (i) an adaptation of a short questionnaire previously
used successfully for elderly American adults(11), incor-
porating a food security question; and (ii) a test of intake
of a standard porridge, similar to tests validated in young
children in Benin(9) and also used for young South
African children(12) and Kenyan schoolchildren(13).
We compared these two tests with body weight changes
over time, which we considered the most robust estimate
of energy intake of adults recovering from malnutrition.
Methods
The study was embedded in the NUSTART trial (trial regis-
tration # PACTR201106000300631) conducted in Mwanza,
Tanzania and Lusaka, Zambia from August 2011 and used
data entered to the end of June 2013 although the main
NUSTART trial continued to recruit. HIV-infected male and
female participants were recruited to the NUSTART trial if
they: (i) were at least 18 years old; (ii) were ART-naïve
except for standard regimens to prevent maternal-to-child
HIV transmission; (iii) had BMI<18·5 kg/m2; (iv) required
ART as determined by CD4 count < 350 cells/μl or WHO
stage 3 or 4 disease; (v) were willing to undertake intensive
follow-up in the study clinic; and (vi) provided written or
thumbprint, informed consent. NUSTART is an individually
randomized, double-blind, placebo-controlled trial of
vitamin and mineral-fortiﬁed lipid-based nutritional supple-
ments (LNS; prepared by Nutriset, Malauney, France) for
malnourished patients starting ART, with mortality from
recruitment to 12 weeks after starting ART as the primary
outcome. Participants randomized to the intervention arm
were provided with a low-kilojoule (30 g) LNS rich in all
essential micronutrients, except Fe, and electrolytes
(LNS-VM) from recruitment until 2 weeks after starting ART.
ART was provided by routine health services at both sites.
The decision when to start ART is made partly on clinical
grounds, e.g. after stabilization of any associated medical
conditions, and partly on patient readiness to begin lifelong
ART. Following the low-kilojoule supplement, participants
received a high-kilojoule (250 g or 5690 kJ/d (1360 kcal/d))
LNS containing the same vitamins and minerals, plus
Fe, during weeks 2–6 of ART. No supplement was given
from weeks 6 to 12 of ART. Placebo LNS preparations were
identical in total kilojoules, consistency, product quantity,
taste and smell but lacked the vitamin and mineral
fortiﬁcant. The two-step regimen was designed to mimic
standard protocols for management of severe malnutrition in
young children in that there was a stabilization period where
vitamins and minerals were provided and infections were
treated before energy was provided in order to promote
weight gain(4). The trial is ongoing and the investigators
remain blind, but the intervention is not the subject of the
present article.
Patients came to the clinic weekly until the start of ART
for medical examination, questionnaires, anthropometry,
blood sampling for electrolytes, appetite testing and to
pick up their next lot of supplements. Patients also came
to the clinic at weeks 1, 2, 4, 6, 8 and 12 after starting ART.
Height was measured at recruitment and weight at each
visit using a stadiometer ﬁxed to the wall and a digital
balance, respectively; measurements were taken in
triplicate and the median used in analyses. Technical
errors of measurement were assessed using standard
methods and were within acceptable limits for height and
weight at both sites(14).
The appetite questionnaire administered at each visit
contained four questions with graded levels of response
(Table 1). We also used an appetite test that was similar to
an ad libitum maize porridge consumption test previously
validated against 3 d weighed intakes among young
children in Benin(9) and also used in young South African
children(12) and school-aged Kenyan children(13). For the
appetite test, patients were asked to come to the clinic
having fasted since the previous evening; a questionnaire
determined what, if anything, they had eaten since the
night before. A standard porridge was prepared daily
using 1·1 litres of maize meal and 4 litres of water; this was
boiled for 30 min and kept warm until eaten; salt or sugar
was added to taste. Patients were provided with a bowl
containing about 250 g; the bowl and porridge together
were weighed to 10 g precision before giving it to the
participants and after the participants had eaten as much
as they wished in order to calculate amount consumed by
difference. Participants could also request additional
bowls. Due to concern regarding the effect of cultural
norms on patient requests for additional bowls in Zambia,
we increased the ﬁrst bowl weight to 400 g between
19 June and 20 July 2012.
Statistics and data management
Data were double entered into OpenClinica in Zambia and
MySQL in Tanzania. Analysis and data cleaning were
carried out in the Stata statistical software package version
12·1. Analysis was restricted to patients who completed
follow-up to 12 weeks after ART as those who died or
withdrew would be expected to have different proﬁles for
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weight change. Patients who delayed starting ART and
remained on the low-kilojoule supplement for 10 weeks or
more were also excluded from analysis. The four appetite
questions at each patient visit were combined into single
standardized scores by polychoric correlation(15) with
lower scores representing lower appetite.
Changes in appetite score and changes in weight over
time were assessed with regression using restricted cubic
splines with ﬁve knots(16). The time axis was centred
around the date of starting ART; hence visits pre-ART had
negative values. The analysis was stratiﬁed by the number
of weeks spent in the pre-ART phase as this inﬂuenced the
shape of the splines. To determine the association of
appetite score and test results with weight gain, con-
sidered a measure of energy intake, we focused on four
key time points: recruitment, start of ART, 2 weeks after
starting ART at which point the kilojoules provided in the
intervention increased and 6 weeks after starting ART at
which point the intervention ceased. Weight change dur-
ing the following two weeks after appetite assessment was
selected to be long enough to permit detectable weight
change but short enough to limit the amount of change in
clinical condition. Mixed-effects linear regression was used
to compare change in appetite score (divided into a
decrease, change≤ − 0·25; little change, − 0·25< change<
0·25; and an increase, change≥ 0·25) with change in
weight during the subsequent two weeks after the four
key time points; the regression model controlled for sex
and repeated measures of individuals. Additional potential
confounders that were considered a priori were baseline
BMI (divided into< 16·0, 16·0–16·99, 17·0–18·49 kg/m2),
baseline CD4 count (divided into < 50, 50–99, 100–199,
≥200 cells/μl), oedema at baseline, tuberculosis status pre-
ART, socio-economic status (measured by principal com-
ponent analysis(17) within each site since sites differed and
categorized into quintiles) and, for the appetite test,
whether or not the patient was fasting before the test. We
also present the relationship between appetite and overall
change in weight from recruitment to 12 weeks of ART.
Finally, we determined whether a single question about
hunger, #2 on the questionnaire, at a single time point
could be used to predict subsequent two-week weight
gain since this might prove clinically useful.
Ethics
The NUSTART trial was conducted according to guidelines
laid down in the Declaration of Helsinki and all proce-
dures were approved by the ethics committees of the
London School of Hygiene and Tropical Medicine, the
University of Zambia and the National Institute for Medical
Research, Tanzania. Participants provided written or
thumbprint informed consent. Medical care for partici-
pants was provided as needed by study clinicians or the
local referral hospitals.
Results
Patient characteristics and weight changes
Figure 1 shows the patients included in the analyses and
Table 2 provides their sociodemographic and clinical
characteristics at recruitment. Tanzanian patients were
older and had lower CD4 count at screening, were less
Table 1 Appetite questionnaire and baseline responses; Nutritional Support for Africans Starting Antiretroviral Therapy
(NUSTART) trial
Zambians Tanzanians
(n 297) (n 182)*
n % n %
#1 How would you describe your appetite over the past 7 d?
1. Excellent 10 3 13 7
2. Good 109 37 43 24
3. Usual 63 21 55 30
4. Poor 111 37 60 33
5. Very poor, not wanting to eat very much at all 4 1 11 6
#2 Have you been hungry in the past 7 d?
1. Not hungry at all, don’t want to eat or can’t finish my plate of food 86 29 18 10
2. Averagely hungry 98 33 61 34
3. Moderately hungry so needed more than 3 meals per day 104 35 47 26
4. Very hungry often (e.g. hunger interfering with sleep at night or daily activities) 9 3 56 31
#3 Are you usually able to afford enough food to satisfy your hunger?
1. Yes 252 85 131 72
2. No 45 15 51 28
#4 In the past 7 d, how has food usually tasted?
1. Very bad 32 11 9 5
2. Bad 56 19 47 26
3. Average 76 26 52 29
4. Good 126 42 70 38
5. Very good 7 2 4 2
*Five of the 187 did not answer the questionnaire.
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educated, were more likely to be self-employed and were
less likely to be married than Zambian patients. The
median time between recruitment and starting ART was
19 d (interquartile range: 15–26 d). Figure 2 shows weight
over time in the study for male and female participants
starting ART between 14 and 20 d, both the median and
the modal (most frequent) week post-recruitment in the
trial population; curves were similar, although more vari-
able due to smaller sample sizes, for subgroups with other
durations of pre-ART phase and the 14–20 d subgroup was
chosen for simplicity of presentation. From recruitment to
week 12 after starting ART, Tanzanian men had gained a
mean of 6·68 kg (95 % CI 5·48, 7·87 kg, n 77) since
recruitment, Tanzanian women a mean of 5·96 kg (95 % CI
5·24, 6·69 kg, n 110), Zambian men a mean of 3·44 kg
(95 % CI 2·63, 4·24 kg, n 149) and Zambian women a
mean of 4·16 kg (95 % CI 3·45, 4·87 kg, n 148). These
increases represent a signiﬁcant difference by site
(P< 0·01) but no difference between males and females.
About 40 % of the weight increase occurred during the
four weeks the patients were taking the high-kilojoule
supplement and about 35 % occurred prior to starting the
high-kilojoule supplement.
Appetite results
At recruitment, just over a third of patients reported having
low appetite (Table 1) and there were differences in
reporting patterns between Tanzanians and Zambians.
Among Tanzanian patients the appetite score was
approximately normally distributed. Among Zambian
patients the scores were clustered around certain values:
44 % of all responses were good appetite, average or
moderately hungry, could afford food and food tasted
good; a further 10 % of responses were usual appetite,
average hunger, could afford food and food tasted aver-
age. Because of the clustered nature of responses it was
not possible to generate an appetite score for Zambian
Follow-up
Randomized to study by 1 November 2012 (n 1112)
Excluded as BMI > 18·5 kg/m2
(n 39). Provided supplement and
monitored for ethical purposes
Completed follow-up (n 509)
Lost to follow-up (n 315)
Died (n 186)
Discontinued due to adverse event (n 3)
Complete data not entered by 30 June 2013
(n 60)
Remained on low-energy LNS for 10 weeks
or more (n 23)
Completed follow-up and analysed (n 484)
Excluded
Missing weight at week 12 visit (n 2)
Analysis
Fig. 1 (colour online) Flow diagram of patients included in the Nutritional Support for Africans Starting Antiretroviral Therapy
(NUSTART) trial (LNS, lipid-based nutritional supplement)
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patients; therefore, further analyses included results from
Tanzanians only. The varying time pre-ART inﬂuenced
the shape of the appetite score curve over time, speciﬁ-
cally because of the moving zero point of starting ART;
Fig. 3 shows the results for Tanzanian patients with
14–20 d pre-ART. For all Tanzanians, on average appetite
score was low at recruitment (overall: mean − 1·07 for
males, − 0·97 for females), increased considerably during
the pre-ART period, plateaued at the start of ART and then
continued to increase more slowly throughout the trial
(at 12 weeks overall: mean 0·93 for males, 0·94 for
females). By 12 weeks of ART the range of responses
had narrowed so that the vast majority of Tanzanian
patients reported excellent or good appetite, moderate
hunger, they could afford food and food tasted good or
very good.
In the standardized porridge consumption test at
recruitment, Tanzanian males ate a mean of 319 g porridge
(95 % CI 297, 342 g, n 77), females 333 g (95 % CI 312,
353 g, n 110), Zambian males 267 g (95 % CI 254, 280 g,
n 130) and females 246 g (95 % CI 235, 257 g, n 136).
In Tanzania, by week 12 there was little change with males
eating a mean of 328 g (95 % CI 309, 348 g, n 77) and
females 337 g (95 % CI 319, 355 g, n 110; Fig. 4). There was
no difference in consumption between patients who had
fasted prior to the test and those who had not fasted
(P= 0·17). The test was not conducted in Zambia at
week 12 but in previous weeks little difference was shown
across time points. Furthermore, in Lusaka, interim
analysis of the results in June 2012 indicated that most
intakes were clustered around 250 g, the amount given
in the ﬁrst bowl, with few patients requesting additional
bowls. Discussion with staff and patients suggested
that patients liked the porridge but cultural norms
prevented many from asking for multiple portions. From
19 June to 20 July 2012, we offered Zambian patients
400 g, instead of 250 g, porridge in the ﬁrst bowl, reverting
back to 250 g as in the protocol after 20 July. The mean
amount consumed at recruitment increased for males
to 334 g (95 % CI 279, 390 g, n 10) and for females to
317 g (95 % CI 267, 366 g, n 14). The squares in Fig. 4(b)
indicate results collected between 20 July and September
2012; most values over 250 g were collected during
this period. Since the results appeared to reﬂect other
factors than appetite, the outcome of interest, the porridge
consumption test was stopped in Lusaka in September
2012.
Associations of appetite with weight change for
Tanzanian patients
Change in appetite score over two weeks from the time
points of recruitment, start of ART, and 2 and 6 weeks
after starting ART was associated with the change in
Table 2 Baseline characteristics of the study population; Nutritional Support for Africans Starting Antiretroviral Therapy
(NUSTART) trial
Zambians Tanzanians
n or Mean % or SD n or Mean % or SD
Population, n and % 297 61 187 39
Age (years), mean and SD 34·7 9·5 38·2 10·3
Sex male, n and % 149 50 77 41
BMI (kg/m2), mean and SD 16·7 1·2 16·6 1·3
BMI category, n and %
< 16·0 kg/m2 72 24 54 29
16·0–16·99 kg/m2 80 27 48 26
17·0–18·49 kg/m2 145 49 85 46
CD4 count (cells/μl), mean and SD 156 96 114 99
Tuberculosis treatment pre-ART, n and % 82 28 43 23
Oedema at recruitment, n and % 8 2·7 4 2·1
Marital status, n and %
Married 154 52 66 35
Widowed/widower 32 11 26 14
Divorced 52 18 72 39
Single – never married 59 20 23 12
Occupation, n and %
Salaried employed 61 21 6 3
Self-employed 82 28 159 85
Housewife 43 15 12 6
Student 6 2 3 2
Unemployed 105 35 7 4
Education, n and %
No education 39 13 50 27
Primary (1–7 grades) 153 52 123 66
Secondary (8–12 grades) 88 30 13 7
Tertiary college/university 17 6 1 0·5
ART, antiretroviral therapy.
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weight during the same two weeks (Table 3). The patients
with an increase in appetite score (change≥0·25) gained a
mean of 41 g more weight daily than those whose appetite
score decreased (change≤− 0·25). There was also an
association with overall changes in appetite score and
weight from recruitment to 12 weeks of ART with a 26 g/d
difference in weight gain between those with increased or
decreased appetite score. There was no evidence that
hunger, measured as question #2 of the questionnaire, was
associated with subsequent change in weight for the key
two-week time periods. The porridge consumption test
showed no association with weight in any of the above
analyses.
Discussion
The aim of the present study was to compare appetite
metrics suitable for use in low-income clinics or ﬁeld
situations to understand and monitor the nutritional
rehabilitation and weight gain of malnourished HIV-
infected adults starting ART. We estimated validity of the
appetite measures by their association with weight
change. Weight change indicates the quantity of food
consumed in a population of free-living adults recovering
from severe malnutrition and mostly without oedema
at baseline, although we accept that weight changes can
be due to hydration changes and that fat and lean tissue
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Fig. 2 Spline curves of participant weight over time for patients starting antiretroviral therapy (ART) 14–20 d after recruitment (Recr)
for (a) fifty-seven Tanzanian women, (b) forty-six Tanzanian men, (c) forty-four Zambian women and (d) forty-seven Zambian men;
Nutritional Support for Africans Starting Antiretroviral Therapy (NUSTART) trial
Appetite in malnourished HIV-infected adults 747
deposited have different weights. Previous work with
HIV-infected British adults showed that energy intake was
the major factor driving weight changes(18). However, a
confounding issue due to our study design is that we
provided more energy to patients from 2 to 6 weeks of
ART and the results suggest that patients needed these
food supplements to gain weight: comparison of Figs 2
and 3 shows that appetite increases preceded weight
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Fig. 3 Spline curve of appetite questionnaire score over time in 103 Tanzanian patients starting antiretroviral therapy (ART) 14–20 d
after recruitment (Recr); Nutritional Support for Africans Starting Antiretroviral Therapy (NUSTART) trial. Lines – – – – – represent
95% CI and are zero at week 0 because the analysis used forced the curves through 0
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Fig. 4 Box-and-whisker plots showing consumption of porridge over time by 187 Tanzanian patients (a) and 297 Zambian patients
(b, c) starting antiretroviral therapy (ART) 14–20 d after recruitment (Recr); Nutritional Support for Africans Starting Antiretroviral
Therapy (NUSTART) trial. Line inside the box represents the median; the bottom and top of the box represent the 25th and 75th
percentile, respectively (i.e. the interquartile range); the whiskers indicate an additional 1·5 × the interquartile range; and open
circles represent outliers. Amount of porridge offered in the first bowl was 250 g in (a) and (b), 400 g in (c). In (b), squares denote
tests after the 400 g test period in Zambia (July/August 2012) and before the decision to stop appetite testing in Zambia
(September 2012)
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increases and a large proportion of the weight gain was
during the period that more energy was provided.
Among Tanzanian patients, a short questionnaire was
used to develop an overall population appetite score. This
score was able to detect change in appetite that was
associated with weight gain during the same two-week
period or over the entire study. However, hunger score at
the start of a two-week interval did not predict subsequent
weight gain. The questionnaire could thus be used to
understand appetite changes in the population but would
not be useful clinically to detect patients who will respond
well to nutritional therapy or who may need more inten-
sive care or appetite stimulants.
A previous study conducted among malnourished HIV-
infected adults starting ART in Lusaka measured appetite
by a single question and compared it with dietary intake
measured by 24 h dietary recall at recruitment and weeks
1, 4 and 12 after starting ART(19). The self-reported appe-
tite was associated with energy intake from dietary recall
but it is difﬁcult to assess energy intake by 24 h recall
because of the need to assess portion size, and all intakes
seemed low. Intake at baseline was not signiﬁcantly
associated with mortality to 12 weeks of ART but an
increase in intake during this period was associated with
increased survival. Our results provide comparable infor-
mation that it is change in appetite – rather than appetite at
a particular time, which may be heavily inﬂuenced by
other patient characteristics and perceptions – that is more
clinically meaningful.
The porridge consumption test of appetite, in addition
to being more time-consuming and complex to carry out,
did not vary over time in the study and was not associated
with weight change. The test may actually be a better
indicator of satiety, a feeling associated with the end of a
meal, than with appetite, a feeling prior to eating. Ill
patients may feel hungry but then ﬁnd they are unable to
eat much.
The spline curves of appetite score over time among
Tanzanian patients showed complex changes of relevance
to clinical care of such patients. There was a rapid increase
in appetite between referral for ART and actually starting
ART. During this interval patients were provided with
treatments for opportunistic infections and other illnesses,
counselling by medical staff and, for the intervention
group, LNS containing high levels of vitamins and miner-
als; any of these could have resulted in improved appetite.
Table 3 Mean weight gain (g/d) and 95% confidence interval in relation to change in appetite for the same period in Tanzanian patients;
Nutritional Support for Africans Starting Antiretroviral Therapy (NUSTART) trial
Time period and appetite measure
Unadjusted Model 1 Model 2
g/d 95% CI g/d 95% CI g/d 95% CI
Change in polychoric appetite score
Key two-week times
Decrease 42 25, 60 29 3, 55 20 −21, 61
Little change 70 46, 94 58 28, 88 49 6, 92
Increase 84 70, 97 70 48, 91 61 24, 100
P=0·001 P=0·001 P=0·002
All follow-up
Decrease 28 6, 51 26 3, 49 52 20, 84
Little change 50 28, 70 45 23, 67 62 34, 91
Increase 59 53, 65 56 48, 64 78 59, 98
P= 0·03 P=0·03 P=0·05
Change in appetite consumption test
Key two-week times
Decrease 76 57, 96 62 36, 88 53 12, 95
Little change 66 52, 80 51 28, 74 41 0, 82
Increase 68 46, 91 46 18, 74 41 − 1, 84
P= 0·69 P=0·52 P=0·61
All follow-up
Decrease 57 45, 69 55 42, 67 76 55, 97
Little change 56 46, 65 52 41, 64 77 54, 101
Increase 55 46, 64 52 42, 63 77 57, 97
P= 0·98 P=0·94 P=0·98
Hunger questionnaire at beginning of time period
Key two-week times
Not hungry 106 55, 157 95 45, 146 84 23, 145
Average hunger 61 40, 81 49 23, 75 47 6, 88
Moderately hungry 71 57, 86 64 38, 90 57 17, 98
Very hungry 62 43, 82 52 27, 78 43 2, 84
P= 0·36 P=0·28 P=0·40
ART, antiretroviral therapy.
Model 1 is adjusted for sex and, for the key two-week time data, also the key time point: recruitment, ART, ART+2 or ART+6. Model 2 is adjusted for sex, key
time point (if appropriate), baseline BMI group, baseline CD4 group, socio-economic status, oedema at baseline, tuberculosis diagnosis pre-ART. P values are
for the effect of the appetite variables in the linear regression models.
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Whether this resulted in a harmful refeeding syndrome
cannot be determined from the data but the fact that
increased diet intake in the previous Lusaka study was
associated with increased survival(19) suggests refeeding
syndrome may not have been of major importance in this
patient population. The start of ART was associated with a
brief period when appetite plateaued, possibly a reaction
to the drugs themselves. Although, likely for logistic rea-
sons, food supplementation programmes often target
patients starting ART(2,20), it may be preferable to delay a
few weeks until appetite is restored. Preliminary data from
Ethiopia(21) showed that the timing of nutritional support
with LNS affected its impact on lean mass and functional
outcomes. Finally, the longer-term increases in appetite
after several weeks of ART support evidence that appetite
increases with ART and may reduce ART adherence
among food-insecure patients(8). These observations pro-
vide evidence for targeting nutritional support to mal-
nourished or food-insecure patients after several weeks
of ART.
A limitation of both appetite tests is that they provided
reliable results in only one of the two study sites.
Responses to the questionnaire were highly clustered in
Zambia and likely reﬂected a combination of patients
providing socially acceptable responses and nurses having
trouble interpreting or explaining the questions; for
example, some nurses interpreted the ﬁrst question to
mean usual appetite during the past few months of
advanced HIV infection, not usual compared with healthy
people. Part of the difﬁculty with the porridge consump-
tion appetite test in Zambia appeared to be cultural in that
people seemed willing to eat whatever amount of porridge
was given, even when this was increased from 250 g to
400 g, but not to ask for second bowls. Such cultural
inﬂuences are likely stronger among adults than among
young children fed by their mothers or even among pri-
mary school-aged children in whom similar tools have
been used successfully in Africa(9,13). In addition, there
appeared to be some subtle and unrecorded aspect of the
study nurses’ behaviour in offering the porridge since
there was an increase in requests for second bowls once
the issue became a topic of discussion in the Zambian
clinic. There may also have been differences in approach
of the nurses in Tanzania from those in Zambia, even
though all were following the same trial standard operat-
ing procedures. Our overall interpretation of a standar-
dized meal as a test of appetite in adults is that it is too
sensitive to minor differences in testers’ attitudes, taste
preferences of patients or to even the cultural differences
between two cities in adjacent sub-Saharan African
countries to be useful. However, the simple questionnaire,
with additional training or minor modiﬁcation, could likely
be used successfully in Zambia as well as Tanzania.
An additional limitation of our study is that we remain
blind to treatment allocation. The trial intervention pro-
ducts were two different food supplements, varying in
vitamin and mineral content. A multiple micronutrient
intervention increased appetite, measured by a standar-
dized porridge intake test, among young HIV-infected
South African children(12) and Fe supplementation
increased appetite, measured by both a standardized
porridge intake test and a single question about appetite,
among school-aged Kenyan children(13). The intervention
products may also have inﬂuenced the proportion lean or
fat mass deposited, which would affect the association
between appetite and weight change.
We conclude that a simple appetite questionnaire can
be used to assess appetite among Tanzanian adults and
could likely be adapted to work successfully for Zambian
adults also. The questionnaire appeared not very useful as
a clinical marker for individual patients, for example, of
when to change from an initial stabilization phase in the
management of malnutrition to provision of additional
energy, since responses at a single time point did not
predict subsequent weight change. However, the ques-
tionnaire may be useful for research and for guiding pro-
grammes; speciﬁcally, the results suggest that high-energy
supplements for malnourished, HIV-infected adults should
be targeted to patients who have been on ART several
weeks when infections have been controlled and the
appetite plateau at the start of ART has resolved.
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